Clinical Outcomes Following a Patient-Centered Educational Intervention on Steatotic Liver Disease: A Comparison of Patients With and Without Diabetes
Background and Aims: Steatotic liver disease (SLD) is strongly associated with diabetes. These diseases disproportionately impact marginalized populations, for whom lifestyle modifications, a mainstay of treatment, can be challenging. This study aimed to assess change in liver enzyme alanine aminotr...
Saved in:
| Main Authors: | Rebecca G. Kim, Shyam Patel, Amy M. Shui, Catherine Magee, Jennifer Y. Chen, Michele Tana, Mandana Khalili |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Gastro Hep Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572325000974 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECTIVENESS OF WALKING EXERCISE ON HBA1C AND BMI OF DIABETES MELLITUS TYPE 2: A SYSTEMATIC REVIEW
by: Nurul Fitri, et al.
Published: (2024-12-01) -
Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?
by: Joana Nicolau, et al.
Published: (2025-07-01) -
Association of gut microbiota dietary index with metabolic dysfunction-associated steatotic liver disease: the mediating roles of inflammation and body mass index
by: Yu Pu, et al.
Published: (2025-05-01) -
Investigating the potential role of T helper 17 cells among women experiencing overweight and obesity and their possible therapeutic targeting of the RORγt molecule
by: Renad M. Alhamawi, et al.
Published: (2024-11-01) -
Post‐hoc analysis of the tofogliflozin post‐marketing surveillance study (J‐STEP/LT): Tofogliflozin improves liver function in type 2 diabetes patients regardless of BMI
by: Hiroyuki Uchinuma, et al.
Published: (2025-04-01)